Simulations Plus, Inc. (NASDAQ:SLP) Signals Short-Term Pullback Despite WMDST Valuation Edge

Simulations Plus shows a divergence between technical momentum and fundamental value: technicals point toward near-term downside while fundamentals and WMDST valuation indicate the stock sits below intrinsic support. Recent corporate actions create event-driven attention that may compress trading ranges.

Recent News

May 21, 2026 — a shareholder alert named a law firm investigation into the company’s officers and directors. Mid‑June filings and press coverage disclose an Agreement and Plan of Merger executed with an affiliate of Altaris, with press reporting the proposed cash consideration at $18.50 per share. These items dominate headlines and may drive near-term liquidity and attention.

Technical Analysis

ADX at 37.85 indicates a strong trend environment; that strength amplifies directional signals and increases the likelihood that recent momentum will persist in the short term.

DI+ measures 26.89 and shows a decreasing trajectory while DI- registers 13.26 and trends upward; that pair indicates directional pressure favoring sellers and supports a near-term bearish bias against the current valuation level.

MACD sits at 0.17 below its signal line at 0.23 and shows a decreasing trend; the MACD below its signal line confirms weakening bullish momentum and aligns with a short-term loss of upward impulse.

MRO reads 21.12 with a peak-and-reversal pattern; the positive MRO plus the reversal pattern implies price currently exceeds short-term target levels and increases the probability of a pullback toward modeled targets.

RSI at 62.58 with a peak-and-reversal signal points to momentum exhaustion rather than oversold conditions, consistent with near-term topping pressure despite remaining below extreme overbought levels.

Price action sits essentially at the 20‑day average ($18.32) and above the 50‑day ($17.86) and 200‑day ($16.26) averages, so intermediate support exists beneath current levels; however, the 12‑day EMA shows a peak-and-reversal, reinforcing short-term downside risk even while longer-term averages remain constructive.

Bollinger band width remains extremely narrow (upper ≈ $18.35, lower ≈ $18.29), indicating low volatility and a compressed range; volume remains below 50‑ and 200‑day averages, showing limited conviction behind recent moves and leaving room for volatility if news flow intensifies.

 


Fundamental Analysis

Total revenue reached $21,886,000 for the period ending 2026-05-31, with YoY revenue growth of +7.35% and quarter-over-quarter revenue change of -131.07% (QoQ). Gross profit totaled $15,127,000 and gross margin at 69.12% improved YoY by +7.999% and QoQ by +4.003%, supporting operating leverage on higher‑margin product and services mix.

Operating income (EBIT) measured $4,499,000 with an operating margin of 20.56%. Operating margin rose YoY by +39.77% but contracted QoQ by -11.30%. The operating margin of 20.56% sits slightly below the industry peer mean of 22.91% and below the industry peer median of 30.93% on the same metric, indicating margin performance close to, but under, the peer average.

Net income totaled $3,575,000 and EPS came in at $0.30 versus an estimate of $0.23, producing an EPS surprise ratio of +30.44%. Free cash flow reached $7,948,000 and free cash flow yield stands at 2.42%, below the industry peer mean free cash flow yield of 3.14% but reflecting healthy cash generation relative to reported earnings (cash flow to earnings ≈ 2.22x).

Balance sheet liquidity remains a strength: cash and short‑term investments total $49,990,000, current ratio 5.54, and cash ratio 3.68. Total debt equals $487,000, producing a debt-to-equity of roughly 0.35% and a debt-to-assets ratio near 0.32%, supporting low financial risk and capital flexibility. Interest coverage sits at 6.12x, indicating the company covers interest obligations comfortably.

Valuation multiples show higher market expectations: trailing P/E ≈ 54.17 and forward P/E ≈ 65.61, while price-to-sales ≈ 15.01 and enterprise/revenue (EVR) ≈ 12.75 with an enterprise multiple of ≈ 47.56. Book value per share stands at $6.88 and the price‑to‑book ratio equals 2.36, below the industry peer mean price‑to‑book of 3.53 and below the industry peer median of 3.87, indicating the market prices the company below peer book multiples despite elevated earnings multiples.

Operational efficiency measures: asset turnover at 0.146 sits above the industry peer mean of 0.1107 and the industry peer median of 0.0975, signaling relatively efficient revenue generation from assets. Cash conversion cycle of 56.73 days sits slightly below the industry peer mean of 57.95 days, supporting cash conversion versus peers.

WMDST values the stock as under‑valued. The valuation view anchors on a strong cash position, minimal leverage, positive free cash flow, and a price‑to‑book below peer averages, offset by elevated P/E multiples and a lower free cash flow yield versus the industry peer mean.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2026-05-31
REPORT DATE: 2026-07-09
NEXT REPORT DATE: 2026-10-08
CASH FLOW  Begin Period Cash Flow 25.7 M
 Operating Cash Flow 8.7 M
 Capital Expenditures -761.00 K
 Change In Working Capital
 Dividends Paid
 Cash Flow Delta 9.6 M
 End Period Cash Flow 35.3 M
 
INCOME STATEMENT REVENUE
 Total Revenue 21.9 M
 Forward Revenue 6.8 M
COSTS
 Cost Of Revenue 6.8 M
 Depreciation 1.4 M
 Depreciation and Amortization 1.4 M
 Research and Development 3.4 M
 Total Operating Expenses 17.4 M
PROFITABILITY
 Gross Profit 15.1 M
 EBITDA 5.9 M
 EBIT 4.5 M
 Operating Income 4.5 M
 Interest Income 344.0 K
 Interest Expense
 Net Interest Income 344.0 K
 Income Before Tax 4.8 M
 Tax Provision 1.2 M
 Tax Rate 26.0 %
 Net Income 3.6 M
 Net Income From Continuing Operations 3.6 M
EARNINGS
 EPS Estimate 0.23
 EPS Actual 0.30
 EPS Difference 0.07
 EPS Surprise 30.435 %
 Forward EPS 0.22
 
BALANCE SHEET ASSETS
 Total Assets 153.0 M
 Intangible Assets 71.4 M
 Net Tangible Assets 67.6 M
 Total Current Assets 75.1 M
 Cash and Short-Term Investments 50.0 M
 Cash 35.3 M
 Net Receivables 17.2 M
 Inventory
 Long-Term Investments 1.4 M
LIABILITIES
 Accounts Payable 2.2 M
 Short-Term Debt
 Total Current Liabilities 13.6 M
 Net Debt
 Total Debt 487.0 K
 Total Liabilities 13.9 M
EQUITY
 Total Equity 139.0 M
 Retained Earnings -25.58 M
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 6.88
 Shares Outstanding 20.216 M
 Revenue Per-Share 1.08
VALUATION
 Market Capitalization 328.5 M
 Enterprise Value 279.0 M
 Enterprise Multiple 47.561
Enterprise Multiple QoQ 44.688 %
Enterprise Multiple YoY -20.434 %
Enterprise Multiple IPRWA high: 137.95
median: 73.952
mean: 67.88
SLP: 47.561
low: -20.4
 EV/R 12.75
CAPITAL STRUCTURE
 Asset To Equity 1.1
 Asset To Liability 10.973
 Debt To Capital 0.003
 Debt To Assets 0.003
Debt To Assets QoQ -8.357 %
Debt To Assets YoY -40.561 %
Debt To Assets IPRWA high: 0.576
mean: 0.042
median: 0.011
low: 0.009
SLP: 0.003
 Debt To Equity 0.004
Debt To Equity QoQ -7.895 %
Debt To Equity YoY -39.759 %
Debt To Equity IPRWA high: 3.104
mean: 0.107
median: 0.014
low: 0.011
SLP: 0.004
PRICE-BASED VALUATION
 Price To Book (P/B) 2.363
Price To Book QoQ 14.016 %
Price To Book YoY -15.297 %
Price To Book IPRWA high: 5.885
median: 3.869
mean: 3.531
SLP: 2.363
low: 0.094
 Price To Earnings (P/E) 54.171
Price To Earnings QoQ 38.178 %
Price To Earnings YoY 0.456 %
Price To Earnings IPRWA high: 220.299
median: 77.436
mean: 72.271
SLP: 54.171
low: -35.545
 PE/G Ratio -3.792
 Price To Sales (P/S) 15.012
Price To Sales QoQ 31.524 %
Price To Sales YoY -11.478 %
Price To Sales IPRWA high: 50.378
median: 32.011
mean: 26.968
SLP: 15.012
low: 0.761
FORWARD MULTIPLES
Forward P/E 65.611
Forward PE/G -4.593
Forward P/S 48.129
EFFICIENCY OPERATIONAL
 Operating Leverage 2.029
ASSET & SALES
 Asset Turnover Ratio 0.146
Asset Turnover Ratio QoQ -14.455 %
Asset Turnover Ratio YoY 20.513 %
Asset Turnover Ratio IPRWA high: 0.353
SLP: 0.146
mean: 0.111
median: 0.098
low: 0.028
 Receivables Turnover 1.237
Receivables Turnover Ratio QoQ -22.759 %
Receivables Turnover Ratio YoY -4.975 %
Receivables Turnover Ratio IPRWA high: 2.963
SLP: 1.237
mean: 1.099
median: 0.966
low: 0.949
 Inventory Turnover
Inventory Turnover Ratio QoQ
Inventory Turnover Ratio YoY
Inventory Turnover Ratio IPRWA
 Days Sales Outstanding (DSO) 73.739
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 56.733
Cash Conversion Cycle Days QoQ 21.064 %
Cash Conversion Cycle Days YoY
Cash Conversion Cycle Days IPRWA high: 94.513
median: 69.215
mean: 57.951
SLP: 56.733
low: -15.96
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 0.356
 CapEx To Revenue -0.035
 CapEx To Depreciation -0.556
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 139.0 M
 Net Invested Capital 139.0 M
 Invested Capital 139.0 M
 Net Tangible Assets 67.6 M
 Net Working Capital 61.6 M
LIQUIDITY
 Cash Ratio 3.685
 Current Ratio 5.538
Current Ratio QoQ 1.173 %
Current Ratio YoY 8.359 %
Current Ratio IPRWA high: 9.945
SLP: 5.538
median: 4.738
mean: 4.343
low: 1.021
 Quick Ratio
Quick Ratio QoQ
Quick Ratio YoY
Quick Ratio IPRWA
COVERAGE & LEVERAGE
 Debt To EBITDA 0.083
 Cost Of Debt 109.867 %
 Interest Coverage Ratio 6.123
Interest Coverage Ratio QoQ -20.089 %
Interest Coverage Ratio YoY 50.217 %
Interest Coverage Ratio IPRWA high: 33.284
median: 9.029
mean: 8.316
SLP: 6.123
low: -15.488
 Operating Cash Flow Ratio 0.541
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 17.006
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate 4.432 %
 Revenue Growth -9.901 %
Revenue Growth QoQ -131.071 %
Revenue Growth YoY 7.351 %
Revenue Growth IPRWA high: 7.736 %
median: 5.622 %
mean: 4.758 %
SLP: -9.901 %
low: -12.762 %
 Earnings Growth -14.286 %
Earnings Growth QoQ -108.442 %
Earnings Growth YoY -131.633 %
Earnings Growth IPRWA high: 122.222 %
mean: 8.999 %
median: 8.738 %
SLP: -14.286 %
low: -200.0 %
MARGINS
 Gross Margin 69.117 %
Gross Margin QoQ 4.003 %
Gross Margin YoY 7.999 %
Gross Margin IPRWA high: 89.522 %
median: 74.979 %
mean: 72.554 %
SLP: 69.117 %
low: 12.388 %
 EBIT Margin 20.557 %
EBIT Margin QoQ -11.304 %
EBIT Margin YoY 39.767 %
EBIT Margin IPRWA high: 30.932 %
median: 30.932 %
mean: 22.914 %
SLP: 20.557 %
low: -79.321 %
 Return On Sales (ROS) 20.557 %
Return On Sales QoQ -11.304 %
Return On Sales YoY 39.767 %
Return On Sales IPRWA high: 30.932 %
median: 30.932 %
mean: 23.055 %
SLP: 20.557 %
low: -81.621 %
CASH FLOW
 Free Cash Flow (FCF) 7.9 M
 Free Cash Flow Yield 2.419 %
Free Cash Flow Yield QoQ 20.169 %
Free Cash Flow Yield YoY 18.404 %
Free Cash Flow Yield IPRWA high: 6.843 %
median: 3.988 %
mean: 3.135 %
SLP: 2.419 %
low: -14.954 %
 Free Cash Growth 42.437 %
Free Cash Growth QoQ -37.006 %
Free Cash Growth YoY -13.183 %
Free Cash Growth IPRWA high: 219.25 %
SLP: 42.437 %
mean: -13.127 %
median: -52.29 %
low: -308.543 %
 Free Cash To Net Income 2.223
 Cash Flow Margin 33.547 %
 Cash Flow To Earnings 2.054
VALUE & RETURNS
 Economic Value Added 0.04
 Return On Assets (ROA) 2.388 %
Return On Assets QoQ -25.141 %
Return On Assets YoY -105.956 %
Return On Assets IPRWA high: 2.882 %
median: 2.882 %
SLP: 2.388 %
mean: 2.239 %
low: -10.518 %
 Return On Capital Employed (ROCE) 3.227 %
 Return On Equity (ROE) 0.026
Return On Equity QoQ -24.159 %
Return On Equity YoY -104.727 %
Return On Equity IPRWA high: 0.064
median: 0.036
mean: 0.027
SLP: 0.026
low: -0.174
 DuPont ROE 2.621 %
 Return On Invested Capital (ROIC) 2.407 %
Return On Invested Capital QoQ -25.779 %
Return On Invested Capital YoY 9.409 %
Return On Invested Capital IPRWA high: 3.643 %
median: 2.808 %
SLP: 2.407 %
mean: 2.053 %
low: -10.271 %

Six-Week Outlook

Near term: technical indicators point toward a pullback or consolidation. Directional indicators (DI+ falling, DI- rising) and MACD below its signal indicate diminished upward momentum; MRO and RSI peak‑and‑reversal patterns add pressure for a retracement toward short‑term moving averages or modeled targets. Event risk from the announced merger agreement and ongoing shareholder litigation drives asymmetric attention that may compress the trading range or create sharp, news‑driven moves.

Intermediate bias: underlying fundamentals — ample cash ($49.99M), low debt, positive free cash flow, and operating margin improvement YoY — support the WMDST under‑valued assessment, establishing a constructive medium horizon backdrop if momentum stabilizes and news flow clarifies the merger path.

About Simulations Plus, Inc.

Simulations Plus, Inc. (NASDAQ:SLP) develops advanced software solutions for drug discovery and development, leveraging artificial intelligence and machine learning technologies. The company operates through its Software and Services segments, offering a range of products designed to simulate and predict molecular properties and interactions. Key offerings include GastroPlus, which models the absorption and interaction of compounds in humans and animals, as well as DDDPlus and MembranePlus simulation tools. Simulations Plus also provides mechanistic and mathematical model-based products such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym. These products assist in understanding complex biological systems and drug interactions. The company offers the ADMET Predictor, a chemistry-based program that predicts molecular properties from structures, and the MedChem Designer for molecular design and analysis. Additionally, Simulations Plus delivers consulting services in clinical pharmacology, including population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, and clinical trial simulations. Their consulting services support regulatory submissions and early drug discovery efforts. The company’s clientele spans pharmaceutical, biotechnology, agrochemical, cosmetics, and food industries, as well as academic and regulatory institutions. Established in 1996, Simulations Plus is headquartered in Lancaster, California.



© 2026 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.